Dr James T Brom Psc Optometrist Medicare: Medicare Enrolled Practice Location: 2135 Argillite Rd Ste J, Flatwoods, KY 41139 Phone: 606-836-8153 Fax: 606-834-9420 |
Dr. James T Brom, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2135 Argillite Rd, Flatwoods, KY 41139 Phone: 606-836-8153 Fax: 606-834-9420 |
News Archive
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.
The focus of the Uniting to Combat Neglected Tropical Diseases: Translating the London Declaration into Action conference, which took place November 16-18 in Washington, D.C., was "how we can work together to put the right systems in place and implement the change needed" to control or eliminate neglected tropical diseases (NTDs) by 2020, Simon Bush, director of NTDs at Sightsavers, writes in the Huffington Post U.K.'s "Impact" blog.
A compound which acts in the opposite way as growth hormone can reverse some of the signs of aging, a research team that includes a Saint Louis University physician has shown. The finding may be counter-intuitive to some older adults who take growth hormone, thinking it will help revitalize them.
Lundbeck Inc. today announced the presentation of results from an open-label extension study of Xenazine- (tetrabenazine) for the treatment of chorea associated with Huntington's disease (HD). Data from this study demonstrated that after an 80-week treatment period, subjects treated with Xenazine experienced a statistically significant reduction in chorea score (p< 0.0001) as measured using the Unified Huntington's Disease Rating Scale (UHDRS) compared with baseline.
› Verified 3 days ago